Reply: rationale for anticoagulant therapy of pulmonary fibrosis.
1 University of Chicago Chicago, Illinois.
Imre
I
Noth
Mitchell A
MA
Olman
D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D008297:Male; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin